EPC226 | Long-term follow-up of individuals using HIV post-exposure prophylaxis-in-pocket ('PIP') for high risk, low frequency exposures | E-poster | Scale up of PEP |
EPB150 | Long-term integrated analysis of B/F/TAF in treatment-naïve adults with HIV through five years of follow-up | E-poster | ART in acute, first- and second-line therapies |
OAB0105 | Long-term risk of hospitalization and chronic disease among children who were HIV-exposed uninfected (cHEU) compared to population controls in Montreal, Canada | Oral abstract session with live Q&A | HIV-exposed uninfected children |
EPB057 | Long-term serologic responses to different combinations of inactivated hepatitis A virus vaccines among people living with HIV | E-poster | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
EPC023 | Long-term virological treatment outcomes in adolescents and young adults living with HIV with perinatally and behaviourally acquired infection in the Netherlands | E-poster | Epidemiology of HIV in adolescents |
EPC465 | Lopinavir/Ritonavir post-exposure prophylaxis did not protect against Covid-19 | E-poster | COVID-19 prevention |
EPC431 | Loss to follow-up in HIV care: Issues in retention and re-engagement among People Living with HIV (PLHIV) in 13 African countries | E-poster | Strategies to improve re-engagement |
EPE306 | Lost to HIV care in the context of deep-rooted inequities in Winnipeg, MB, Canada | E-poster | Systems serving underserved populations |
EPC261 | Low awareness of pre-exposure prophylaxis among female sex workers in Togo | E-poster | HIV prevention services for key populations |
EPC016 | Low birth weight among infants born to women living with HIV and HIV-uninfected women at CA-IeDEA sites in Rwanda | E-poster | Epidemiology of HIV in women |